Public-registry trials using DPI-386 Nasal Gel that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness | Repurposed Therapeutics, Inc. | Motion Sickness | PHASE2 / PHASE3 | 1 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →